Watchdog Calls for Oversight of Elderly Drugging and Electroshock in Texas and Nationwide
Found this article helpful?
Share it with your network and spread the knowledge!

A federal watchdog report has found that nursing homes continue using antipsychotics as chemical restraints, sometimes without first attempting required non-drug interventions, and national data showed antipsychotic use among adults aged 65 and older increased nearly 52% between 2015 and 2024, while long-term use increased almost 65%. The Citizens Commission on Human Rights (CCHR) International is demanding greatly increased oversight of the drugging of the elderly and the administration of electroshock treatment, a practice it says should be prohibited.
The recommendations align with a federal assessment that antipsychotic use among nursing home residents remains concerning despite a decade of efforts to reduce it. The drugs carry severe side effects for elderly people with dementia, and the Food and Drug Administration issued a boxed warning against their use in this population because of the increased risk of death. Studies link newer antipsychotics in older adults with dementia to sharply higher risks of stroke, heart failure, accelerated cognitive decline, and bone fractures from falls.
The Health and Human Services Office of Inspector General has flagged the sedative effect of these drugs, raising concerns that nursing homes may use them to control residents' behavior for the benefit of staff. Investigators found that some medical directors failed to prevent inappropriate use, nursing home pharmacists did not identify medical concerns or recommend dose reductions, and inadequate policies undermined safeguards meant to protect residents, even though the Centers for Medicare & Medicaid Services has taken steps to discourage the practice.
The human cost is clear. Lori Smetanka, executive director of the National Consumer Voice for Quality Long-Term Care, noted that facilities are quieting residents down instead of addressing the root problem, which leads to significant problems with their health and well-being.
The risk extends further. Nearly every person diagnosed with dementia, up to an estimated 97%, will eventually experience changes in mood, perception or behavior, placing them at risk of both psychotropic drugs and electroconvulsive therapy, also known as electroshock. According to The New York Times, elderly persons have been electroshocked after they are already prescribed so many other drugs that a powerful psychiatric drug cannot be safely added. A psychiatrist writing in Ethical Human Psychology and Psychiatry warned that electroshock is especially devastating to the vulnerable brain and body of the elderly.
Medicare data illustrate the scale of electroshock use among seniors. Between 2012 and 2014, the program paid $29.6 million to physicians for administering and monitoring treatments, and more than 125,500 sessions occurred in 2014 alone. In 2018, 20,436 beneficiaries received nearly 116,000 treatments. A clinical neuropsychology study of 62 non-demented elderly depressed patients found that 40% showed significant individual-level decline within one week after treatment, and a 1993 Brown University study found elevated mortality risks for patients 80 and older. The FDA has listed cardiac ischemia, arrhythmias, prolonged apnea, and death among potentially significant adverse events associated with the devices.
Jan Eastgate, president of CCHR International, stated that the cumulative picture is one of institutionalization that too often relies on drugs, electroshock, and restraints rather than addressing root causes, and she called for intense oversight, an end to forced psychiatric treatment, and the adoption of safer alternatives. CCHR encourages reporting psychiatric abuse of the elderly and advises individuals to contact their Congressional and state representatives to demand strict enforcement of non-drug interventions and a prohibition on electroshock for all. The group, a mental health watchdog established in 1969 by the Church of Scientology and psychiatrist Thomas Szasz, investigates and exposes psychiatric abuses to protect vulnerable populations, and its CCHR profile outlines that mission.
For Texas, where long-term care operators and the broader senior-care economy are significant employers, the findings carry weight. Families evaluating facilities may press for transparency on antipsychotic use and non-drug care plans, while providers face heightened scrutiny over staffing practices and pharmacy oversight. CCHR has also urged continued attention to the issue, detailing its concerns in prior advisories such as its call for oversight of elderly being electroshocked. The debate now centers on whether oversight and enforcement will shift incentives toward safer alternatives.
